The SMI group Cell and Gene Therapy conference is being held on 10-11 October 2018, in London.
From manufacturing to patient access: discover the world of advanced therapy medicinal products.
Ryan McCoy, Lead Technical Scientist, will be speaking on the topic of Risk-based approaches to cell and gene therapy manufacturing.
- The value of risk and cost based tools in supporting manufacturing development planning
- Logistics-by-design, introducing a framework built on quality by design principles to support therapy developers in planning their commercial logistics strategy.